Anticonvulsants
Research News and Information

Saturday, November 21, 2009

Postoperative nonconvulsive encephalopathic status: identification of a syndrome responsible for delayed progressive deterioration of neurological status after skull base surgery. Clinical article.

30 Oct 2009 OBJECT: Over a 10-year period, the authors have observed a rare but recurring syndrome manifested by a delayed, postoperative, progressive decline in the level of consciousness to deep coma that is time-limited to several days with abrupt awakening. ... Read more...

Efficacy and safety of 800 and 1200 mg eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures.

30 Oct 2009 OBJECTIVES: To evaluate the efficacy and safety of eslicarbazepine acetate (ESL) as adjunctive therapy in adults with partial-onset seizures. MATERIAL AND METHODS: Double-blind, placebo-controlled, parallel-group, multicenter study consisting of an ... Read more...

Death in a toddler following endosulfan ingestion.

30 Oct 2009 INTRODUCTION: Endosulfan, an organochlorine insecticide widely used in agriculture, is rapidly absorbed following ingestion, inhalation, or skin exposure. Poisonings rarely result in morbidity and mortality. Symptoms occur rapidly following exposure ... Read more...

Latest indexed articles for 'Anticonvulsants'

These are the very latest articles for this heading:

• Predictors of awakening from postanoxic status epilepticus after therapeutic hypothermia. Nov 2009
• Postoperative nonconvulsive encephalopathic status: identification of a syndrome responsible for delayed progressive deterioration of neurological status after skull base surgery. Clinical article. 30 Oct 2009
• Efficacy and safety of 800 and 1200 mg eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures. 30 Oct 2009
• Death in a toddler following endosulfan ingestion. 30 Oct 2009
• Bipolar II postpartum depression: Detection, diagnosis, and treatment. 30 Oct 2009
• Lower bispectral index values in children who are intellectually disabled. 30 Oct 2009
• Craniotomy pain: trying to do better. 30 Oct 2009
• Generic drugs revisited. 17 Oct 2009
• Reflections: neurology and the humanities: reflections for October. 11 Oct 2009
• Correlation of enzyme-inducing anticonvulsant use with outcome of patients with glioblastoma. 11 Oct 2009
• [Drug-resistant epilepsy] 6 Oct 2009
• Hughlings Jackson's suggestion for the treatment of epilepsy. 4 Oct 2009
• Prediction of antiepileptic drug efficacy: the use of intracerebral microdialysis to monitor biophase concentrations. 29 Sep 2009
• Epilepsy in later life. 29 Sep 2009
• Effect of CYP3A5*3 genotype on serum carbamazepine concentrations at steady-state in Korean epileptic patients. 29 Sep 2009
• Drug approved to treat infantile spasms. 29 Sep 2009
• Seizure relapse and development of drug resistance following long-term seizure remission. 29 Sep 2009
• Animal models of focal cortical dysplasia and tuberous sclerosis complex: recent progress toward clinical applications. 29 Sep 2009
• Focal brain malformations: seizures, signaling, sequencing. 29 Sep 2009
• Juvenile myoclonic epilepsy 25 years after seizure onset: a population-based study. 27 Sep 2009

See a longer list of these articles.

Technical information about 'Anticonvulsants'

Definition: Drugs used to prevent SEIZURES or reduce their severity.

Registry Number: 0

Descriptor UI: D000927

Alternative terms: Anticonvulsants; Anticonvulsant Drugs; Drugs, Anticonvulsant; Anticonvulsive Drugs; Drugs, Anticonvulsive; Anticonvulsive Agents; Agents, Anticonvulsive; Antiepileptic Agents; Agents, Antiepileptic; Antiepileptic Drugs; Drugs, Antiepileptic; Antiepileptics;

Related Mesh Headings: Seizures;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Tree Number: D27.505.954.427.080;

Technical Notes: GEN or unspecified; prefer specifics; consider also CONVULSIONS /drug ther